Welcome note

Dear Colleague,

It is our pleasure to invite you to participate in the upcoming World Congress on Clinical Trials in Diabetes (WCTD2016), which will take place 30 November - 1 December 2016 in Berlin, Germany.

With the multitude of complex issues associated with clinical trials in diabetes, it is clear that there is a necessity to streamline these issues into a process that will improve drug development in terms of approval and commercialization, and address the various aspects of drug and device development and the way to enhance them.

The world renowned faculty will tackle these issues head on through a comprehensive scientific program which will focus on four key areas:
  • Design the Best Study
  • Improve Regulatory Process; Better Understanding of How to Collaborate with Regulatory Authorities
  • Involvement of Digital Medicine
  • Power Post-Marketing Surveillance
WCTD2016 is a pragmatic event directed at filtering through the information overload of the digital age to deliver targeted information.

The scientific program will have a broad therapeutic focus and tackle both the global and specific regional differences. The program will include speakers such as physicians, R&D personnel, regulatory decision makers, CEOs, CROs, CRAs, Clinical Trial Managers and QA personnel.

We look forward to seeing you at WCTD2016 in the exciting and historical city of Berlin.

Prof. Itamar Raz                                           Bioevents 
Congress Chair                                            Congress Organizer